Interleukin-6 Delays Neutrophil Apoptosis via a Mechanism Involving Platelet-Activating Factor

Journal of Trauma - Injury, Infection and Critical Care

Volumn 40, Issue 4, 1996, Pages 575-578

  Biffl, Walter L ^a   Moore, Ernest E ^a   Moore, Frederick A ^a   Barnett, Carlton C ^a  

^a DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; THROMBOCYTE ACTIVATING FACTOR;

APOPTOSIS; ARTICLE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; INFLAMMATION; INJURY; LEUKOCYTE ACTIVATION; MULTIPLE ORGAN FAILURE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

APOPTOSIS; HUMANS; INFLAMMATION; INTERLEUKIN-6; NEUTROPHILS; PLATELET ACTIVATING FACTOR;

EID: 0029979638     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/00005373-199604000-00009     Document Type: Article

References (43)

1. Castell JV, Gomez-Lechon MJ, David M, et al: Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 242:237, 1989
2. Baigrie RJ, Lamont PM, Kwiatkowski D, et al: Systemic cytokine response after major surgery. Br J Surg 79:757, 1992
3. Damas P, Ledoux D, Nys M, et al: Cytokine serum levels during severe sepsis in humans: IL-6 as a marker of severity. Ann Surg 215:356, 1992
4. Drost AC, Burleson DG, Cioffi WG Jr., et al: Plasma cytokines after thermal injury and their relationship to infection. Ann Surg 218:74, 1993
5. Ertel W, Faist E, Nestle C, et al: Kinetics of interleukin-2 and interleukin-6 synthesis following major mechanical trauma. J Surg Res 48:622, 1990
6. Meduri GU, Headley S, Kohler G, et al: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: Plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107:1062, 1995
7. Roumen RMH, Hendriks T, van der Ven-Jongekrijg J, et al: Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma: Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 218:769, 1993
8. Biffl WL, Moore EE, Moore FA, et al: Interleukin-6 potentiates neutrophil priming with platelet-activating factor. Arch Surg 129:1131, 1994
9. Mullen PG, Windsor ACJ, Walsh CJ, et al: Tumor necrosis factor-α and interleukin-6 selectively regulate neutrophil function in vitro. J Surg Res 58:124, 1995
10. Biffl WL, Moore EE, Moore FA, et al: Interleukin-6 delays neutrophil apoptosis. Arch Surg 131:24, 1996
11. Botha AJ, Moore FA, Moore EE, et al: Early neutrophil priming for superoxide release after injury is via a platelet-activating factor mechanism. Br J Surg 82:686, 1995
12. Kim FJ, Moore EE, Moore FA, et al: Reperfused gut elaborates PAF that chemoattracts and primes neutrophils. J Surg Res 58:636, 1995
13. Mozes T, Braquet P, Filep J: Platelet-activating factor: An endogenous mediator of mesenteric ischemia-reperfusion-induced shock. Am J Physiol 257:R872, 1989
14. Pitman JM III, Thurman GW, Anderson BO, et al: Platelet-activating factor may mediate neutrophil priming following clinical burn or blunt trauma. Surgical Forum XL 108, 1989
15. Stahl GL, Craft DV, Lento PH, et al: Detection of platelet-activating factor during traumatic shock. Circ Shock 26:237, 1988
16. Stahl GL, Bitterman H, Lefer AM: Protective effects of a specific platelet-activating factor antagonist, WEB 2086, in traumatic shock. Thromb Res 53:327, 1989
17. Arnould T, Michiels C, Remade J: Increased PMN adherence on endothelial cells after hypoxia: Involvement of PAF, CD18/CD11b, and ICAM-1. Am J Physiol 264:C1102, 1993
18. Gay JC, Beckman JK, Zaboy KA, et al: Modulation of neutrophil oxidative responses to soluble stimuli by platelet-activating factor. Blood 67:931, 1986
19. Ingraham LM, Coates TD, Allen JM, et al: Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor. Blood 59:1259, 1982
20. Milhoan KA, Lane TA, Bloor CM: Hypoxia induces endothelial cells to increase their adherence for neutrophils: Role of PAF. Am J Physiol 263:H956, 1992
21. Read RA, Moore EE, Moore FA, et al: Platelet-activating factor-induced polymorphonuclear neutrophil priming independent of CD11b adhesion. Surgery 114:308, 1993
22. Biffl WL, Moore EE, Moore FA, et al: Interleukin-6 stimulates neutrophil production of platelet-activating factor. J Leuk Biol (In press)
23. Haslett C, Guthrie LA, Kopaniak MM. et a): Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 119:101, 1985
24. Squier MKT, Miller ACK, Malkinson AM, et al: Calpain activation in apoptosis. J Cell Physiol 159:229, 1994
25. Nuytinck HKS, Offermans XJMW, Kubat K, et al: Whole-body inflammation in trauma patients: An autopsy study. Arch Surg 123:1519, 1988
26. Weiland JE, Davis WB, Holter JF, et al: Lung neutrophils in the adult respiratory distress syndrome: Clinical and pathophysiologic significance. Am Rev Respir Dis 133:218, 1986
27. Wortel CH, Doerschuk CM: Neutrophils and neutrophil-endothelial cell adhesion in adult respiratory distress syndrome. New Horizons 1:631, 1993
28. Kukielka GL, Youker KA, Hawkins HK, et al: Regulation of ICAM-1 and IL-6 in myocardial ischemia: Effect of reperfusion. Ann NY Acad Sci 574:258, 1994
29. Maruo N, Monta I, Shirao M, et al: IL-6 increases endothelial permeability in vitro. Endocrinology 131:710, 1992
30. Deitch EA, Xu D, Franko L, et al: Evidence favoring the role of the gut as a cytokine-generating organ in rats subjected to hemorrhagic shock. Shock 1:141, 1994
31. Ueo H, Inoue H, Honda M, et al: Production of interleukin-6 at operative wound sites in surgical patients. J Am Coll Surg 179:326, 1994
32. Rodriguez JL, Miller CG, Garner WL, et al: Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma 34:684, 1993
33. Braquet P, Touqui L, Shen TY, et al: Perspectives in platelet-activating factor research. Pharmacol Rev 39:97, 1987
34. Stewart AG, Dubbin PN, Harris T, et al: Platelet-activating factor may act as a second messenger in the release of icosanoids and Superoxide anions from leukocytes and endothelial cells. Proc Natl Acad Sci USA 87:3215, 1990
35. Stewart AG, Harris T: Platelet-activating factor may participate in signal transduction processes in rabbit leukocytes. Lipids 26:1044, 1991
36. 2+ in human neutrophils induced by opsonized particles. FEBS Lett 259:209, 1989
37. Haslett C: Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci 83:639, 1992
38. 2. J Leuk Biol 52:269, 1992
39. Steinberg KP, Milberg JA, Martin TR, et al: Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am J Respir Crit Care Med 150:113, 1994
40. Herlihy JP, Vermeulen MW, Joseph PM, et al: Impaired alveolar macrophage function in smoke inhalation injury. J Cell Physiol 163:1, 1995
41. Biffl WL, Moore EE, Moore FA, et al: Interleukin-6 suppression of neutrophil apoptosis is neutrophil concentration dependent. J Leuk Biol 58:582, 1995
42. Casals-Stenzel J: Thieno-triazolo-1,4-diazepines as antagonists of platelet-activating factor: Present status. Lipids 26:1157, 1991
43. Svetlov S, Nigam S: Evidence for the presence of specific high affinity cytosolic binding sites for platelet-activating factor in human neutrophils. Biochem Biophys Res Comm 190:162, 1993